iBio, Inc.IBIONYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +14.29% | +0.00% | -100.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | -220.50% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +392.03% | +165.61% | +90.45% | +513.70% | +985.56% |
| Weighted Average Shares Diluted Growth | +392.03% | +165.61% | +90.45% | +513.70% | +985.56% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -100.00% | -85.27% | +0.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -36.23% | -61.91% | -19.31% | +161.68% | +196.78% |
| Book Value per Share Growth | -69.29% | -82.77% | -63.36% | -48.57% | -62.50% |
| Debt Growth | -76.86% | -78.34% | -21.35% | -22.18% | -38.70% |
| R&D Expense Growth | +22.28% | +110.84% | +182.81% | +172.03% | +128.02% |
| SG&A Expenses Growth | -7.40% | +9.22% | +0.51% | -10.71% | +88.37% |